Stoke Therapeutics, Inc. company logo
Stoke Therapeutics, Inc. logo

Stoke Therapeutics, Inc. (STOK) Cash From Financing

Annual CFF

$131.09M$78.09M+147.31%

Summary

Current Value
As of today, STOK annual cash from financing is $131.09M, up +147.31% on
Historical Performance
STOK annual cash from financing is up +10109.81% over the past 3 years, and down -12.47% over the past 5 years
All-Time High Comparison
STOK annual cash from financing is currently -12.47% below its historical high of $149.76M set on
3-Year Low Comparison
STOK annual cash from financing is +182.48% above its 3-year low of $46.41M reached on an earlier date
Sector Comparison
STOK annual cash from financing is higher than 85.14% of companies in Healthcare sector

Cash From Financing Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

STOK Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash From Financing$131.09M+147.3%+10000.0%-12.5%+2094.4%
Quarterly Cash From Financing$3.12M-61.8%+618.9%+202.0%-74.9%
TTM Cash From Financing$5.62M-95.9%-87.9%+213.4%-54.8%
Price$29.42+226.9%+183.4%-49.6%
Annual Cash From Operations-$86.85M-7.1%-29.8%-179.7%-1513.1%
Annual Cash From Investing-$107.48M-201.4%-40.6%-6477.4%-10000.0%
Annual Dividends Paid$0.000.0%0.0%0.0%0.0%
Annual Total Debt$4.77M-30.1%-5.3%+100.0%+59.1%
Shares Outstanding57.12M+5.7%+44.8%+56.2%

Cash From Financing Highs

STOK Annual Cash From Financing Highs Comparison
PeriodHighDateCurrent
3Y$131.09Mat high
5Y$131.09Mat high
All$149.76M-12.5%

Cash From Financing Lows

STOK Annual Cash From Financing Lows Comparison
PeriodLowDateCurrent
3Y$46.41MN/A+182.5%
5Y$1.28M>+9999.0%
All$1.28M>+9999.0%

Cash From Financing History

YearValueChange
$131.09M+147.3%
$53.01M+14.2%
$46.41M+3,514.4%
$1.28M-98.8%
YearValueChange
$108.11M-27.8%
$149.76M+29.5%
$115.64M+1,835.7%
$5.97M-

FAQ

  • What is the current annual cash from financing of STOK?

    As of today, STOK annual cash from financing is $131.09M

  • What is 1-year change in STOK annual cash from financing?

    STOK annual cash from financing is up +147.31% year-over-year

  • What is 3-year change in STOK annual cash from financing?

    STOK annual cash from financing is up +10109.81% over the past 3 years

  • How far is STOK annual cash from financing from its all-time high?

    STOK annual cash from financing is currently -12.47% below its historical high of $149.76M set on December 31, 2019

  • How does STOK annual cash from financing rank versus sector peers?

    STOK annual cash from financing is higher than 85.14% of companies in Healthcare sector

  • When is STOK next annual earnings release?

    The next annual earnings release for STOK is on

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

Data Sources & References

  1. STOK Official Website www.stoketherapeutics.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1623526/000119312525264720/0001193125-25-264720-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1623526/000095017025041170/0000950170-25-041170-index.htm
  4. STOK Profile on Yahoo Finance finance.yahoo.com/quote/STOK
  5. STOK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/stok